BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21916988)

  • 1. Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study.
    Kim KM; Cho YK; Bae SJ; Kim DS; Shim KN; Kim JH; Jung SW; Kim N
    J Gastroenterol Hepatol; 2012 Apr; 27(4):741-5. PubMed ID: 21916988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
    Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of gastroesophageal reflux disease in Ohio Medicaid patients: practice patterns and temporal trends.
    Cooper GS; Mourad WA; Koroukian SM
    Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):21-7. PubMed ID: 14971119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of the PPI test for detection of GERD in Korean patients and factors associated with PPI responsiveness.
    Cho YK; Choi MG; Lim CH; Nam KW; Chang JH; Park JM; Lee IS; Kim SW; Choi KY; Chung IS
    Scand J Gastroenterol; 2010 May; 45(5):533-9. PubMed ID: 20180645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database.
    Dickman R; Mattek N; Holub J; Peters D; Fass R
    Am J Gastroenterol; 2007 Jun; 102(6):1173-9. PubMed ID: 17378910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
    Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy.
    Nelson SP; Kothari S; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    J Med Econ; 2009; 12(4):348-55. PubMed ID: 19827992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
    Blondeau K; Boecxstaens V; Van Oudenhove L; Farré R; Boeckxstaens G; Tack J
    Neurogastroenterol Motil; 2011 Aug; 23(8):724-e327. PubMed ID: 21535319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence and Clinical Features of Non-responsive Gastroesophageal Reflux Disease to Practical Proton Pump Inhibitor Dose in Korea: A Multicenter Study.
    Park HJ; Park SH; Shim KN; Kim YS; Kim HJ; Han JP; Kim YS; Bang BW; Kim GH; Baik GH; Kim HH; Park SY; Kim SS
    Korean J Gastroenterol; 2016 Jul; 68(1):16-22. PubMed ID: 27443619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a refractory gastro-oesophageal reflux score using an administrative claims database.
    Gerson LB; Bonafede M; Princic N; Gregory C; Farr A; Balu S
    Aliment Pharmacol Ther; 2011 Sep; 34(5):555-67. PubMed ID: 21714794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of gastroesophageal reflux disease in elderly people].
    Masharova AA; Bordin DS
    Eksp Klin Gastroenterol; 2007; (4):37-40. PubMed ID: 18411443
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease.
    Hershcovici T; Jha LK; Gadam R; Cui H; Gerson L; Thomson S; Fass R
    J Clin Gastroenterol; 2012 Sep; 46(8):662-8. PubMed ID: 22858518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
    El-Serag HB; Fitzgerald S; Richardson P
    Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
    Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
    Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of health-care resource utilization according to GERD-associated complications.
    Gerson LB; McLaughlin T; Balu S; Jackson J; Lunacsek O
    Dis Esophagus; 2012; 25(8):694-701. PubMed ID: 22292744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux disease as a cause of death is increasing: analysis of fatal cases after medical and surgical treatment.
    Rantanen TK; Sihvo EI; Räsänen JV; Salo JA
    Am J Gastroenterol; 2007 Feb; 102(2):246-53. PubMed ID: 17156140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.